Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01023 |Industry: Pharmaceuticals
|Expensive Star
4888.65 -53.30 (-1.08%)
NSE Oct 30, 2020 15:31 PM
Volume: 1.3M

BOB Capital Markets Ltd.
Dr Reddy's (DRRD) has announced a key settlement of the patent litigation with Celgene for US Revlimid (lenalidomide capsules) used to treat multiple myeloma.
Dr. Reddy's Laborato.. has an average target of 4961.27 from 13 brokers.
More from Dr. Reddy's Laboratories Ltd.